Mckesson Corp
MCK.N- Latest Trade
- trading lower414.76USD
- -0.04
- 0.01%
- As of Jul 11 2023. Values delayed up to 15 minutes
- Today's Range
- 414.06 - 418.42
- 52 Week Range
- 315.81 - 429.65
- Previous Close
- 414.80
- Open
- 414.72
- Volume
- 204,613.00
- 3 Month Average Trading Volume
- 18.70
- Shares Out (Mil)
- 135.51
- Market Cap
- 56,210.79
- Forward P/E
- 15.60
- Dividend Yield
- 0.52
Key Statistics
1.94 mean rating - 18 analysts
- P/E Excl. Extra Items (TTM)
- 16.54
- Price To Sales (TTM)
- 0.20
- Price To Book (Quarterly)
- 0.00
- Price To Cash Flow (Per Share TTM)
- 12.97
- Total Debt/Total Equity (Quarterly)
- 0.00
- Long Term Debt/Equity (Quarterly)
- 0.00
- Return On Investment (TTM)
- 26.28
- Return On Equity (TTM)
- 5.93
2021 (millions USD)
About Mckesson Corp (MCK.N)
Company Information
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.
Address
6555 State Highway 161IRVING, TX
75039
United States
Industry
Major Drugs
Executive Leadership
- Donald R. Knauss
- Independent Chairman of the Board
- Brian Scott Tyler
- Chief Executive Officer, Director
- Britt J. Vitalone
- Chief Financial Officer, Executive Vice President
- Leann Smith
- Chief Human Resource Officer, Executive Vice President
- Nancy Avila
- Executive Vice President, Chief Technology Officer, Chief Information Officer
- Lori Ann Schechter
- Executive Vice President, Chief Legal Officer, General Counsel
- Tom L. Rodgers
- Executive Vice President, Chief Strategy and Business Development Officer
- Richard H. Carmona
- Independent Director
- Dominic J. Caruso
- Independent Director
- W. Roy Dunbar
- Independent Director
- James H. Hinton
- Independent Director
- Bradley E. Lerman
- Independent Director
- Linda P. Mantia
- Independent Director
- Maria Martinez
- Independent Director
- Susan R. Salka
- Independent Director
- Kathleen Wilson - Thompson
- Independent Director
Latest News
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,926.60 | 0.08% |
| Copper | 722.55 | 0.08% |
| Brent Crude Oil | 77.94 | 0.32% |
| CBOT Soybeans | 1,508.00 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,409.53 | 0.24% |
| Euro STOXX 50 | 4,256.51 | 0.47% |
| FTSE 100 | 7,273.79 | 0.23% |
| Nikkei 225 | 32,403.33 | 0.66% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes